Open Access

Pulmonary fibrosis in the aftermath of the Covid-19 era (Review)

  • Authors:
    • Eirini Vasarmidi
    • Eliza Tsitoura
    • Demetrios A. Spandidos
    • Nikolaos Tzanakis
    • Katerina M. Antoniou
  • View Affiliations

  • Published online on: July 9, 2020     https://doi.org/10.3892/etm.2020.8980
  • Pages: 2557-2560
  • Copyright: © Vasarmidi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The year 2020 is characterized by the COVID‑19 pandemic that has resulted in more than half a million deaths in recent months. The high mortality is associated with acute severe respiratory failure that results in ICU admission and intubation. While facing this fatal disease, research and clinical observations need to be carried out in order to evaluate the long‑term effects of the COVID‑19 acute respiratory distress syndrome (ARDS). Potent clinical and laboratory biomarkers should be studied to be able to predict the subgroup of patients that are going to deteriorate or develop lung fibrosis. The opportunity of personalized medicine is a good way to consider for these patients.

Related Articles

Journal Cover

September-2020
Volume 20 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Vasarmidi E, Tsitoura E, Spandidos DA, Tzanakis N and Antoniou KM: Pulmonary fibrosis in the aftermath of the Covid-19 era (Review). Exp Ther Med 20: 2557-2560, 2020
APA
Vasarmidi, E., Tsitoura, E., Spandidos, D.A., Tzanakis, N., & Antoniou, K.M. (2020). Pulmonary fibrosis in the aftermath of the Covid-19 era (Review). Experimental and Therapeutic Medicine, 20, 2557-2560. https://doi.org/10.3892/etm.2020.8980
MLA
Vasarmidi, E., Tsitoura, E., Spandidos, D. A., Tzanakis, N., Antoniou, K. M."Pulmonary fibrosis in the aftermath of the Covid-19 era (Review)". Experimental and Therapeutic Medicine 20.3 (2020): 2557-2560.
Chicago
Vasarmidi, E., Tsitoura, E., Spandidos, D. A., Tzanakis, N., Antoniou, K. M."Pulmonary fibrosis in the aftermath of the Covid-19 era (Review)". Experimental and Therapeutic Medicine 20, no. 3 (2020): 2557-2560. https://doi.org/10.3892/etm.2020.8980